Literature DB >> 24735884

Hepatic mitochondrial and ER stress induced by defective PPARα signaling in the pathogenesis of hepatic steatosis.

Qiaozhu Su1, Chris Baker2, Patricia Christian2, Mark Naples2, Xuedong Tong3, Kezhong Zhang4, Miklos Santha5, Khosrow Adeli6.   

Abstract

Emerging evidence demonstrates a close interplay between disturbances in mitochondrial function and ER homeostasis in the development of the metabolic syndrome. The present investigation sought to advance our understanding of the communication between mitochondrial dysfunction and ER stress in the onset of hepatic steatosis in male rodents with defective peroxisome proliferator-activated receptor-α (PPARα) signaling. Genetic depletion of PPARα or perturbation of PPARα signaling by high-fructose diet compromised the functional activity of metabolic enzymes involved in mitochondrial fatty acid β-oxidation and induced hepatic mitochondrial stress in rats and mice. Inhibition of PPARα activity further enhanced the expression of apolipoprotein B (apoB) mRNA and protein, which was associated with reduced mRNA expression of the sarco/endoplasmic reticulum calcium ATPase (SERCA), the induction of hepatic ER stress, and hepatic steatosis. Restoration of PPARα activity recovered the metabolic function of the mitochondria and ER, alleviated systemic hypertriglyceridemia, and improved hepatic steatosis. These findings unveil novel roles for PPARα in mediating stress signals between hepatic subcellular stress-responding machinery and in the onset of hepatic steatosis under conditions of metabolic stress.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  apolipoprotein B; endoplasmic reticulum; hepatic steatosis; mitochondrial and endoplasmic reticulum stress; peroxisome proliferator-activated receptor-α; very-low density lipoprotein

Mesh:

Substances:

Year:  2014        PMID: 24735884      PMCID: PMC4280162          DOI: 10.1152/ajpendo.00438.2013

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  35 in total

1.  FoxO1 and hepatic lipid metabolism.

Authors:  Janet D Sparks; Henry H Dong
Journal:  Curr Opin Lipidol       Date:  2009-06       Impact factor: 4.776

Review 2.  Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction.

Authors:  Katsutaro Morino; Kitt Falk Petersen; Gerald I Shulman
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

3.  Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance.

Authors:  Timothy R Koves; John R Ussher; Robert C Noland; Dorothy Slentz; Merrie Mosedale; Olga Ilkayeva; James Bain; Robert Stevens; Jason R B Dyck; Christopher B Newgard; Gary D Lopaschuk; Deborah M Muoio
Journal:  Cell Metab       Date:  2008-01       Impact factor: 27.287

Review 4.  Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system.

Authors:  J K Reddy; T Hashimoto
Journal:  Annu Rev Nutr       Date:  2001       Impact factor: 11.848

5.  The endoplasmic reticulum chaperone improves insulin resistance in type 2 diabetes.

Authors:  Kentaro Ozawa; Mayuki Miyazaki; Munehide Matsuhisa; Katsura Takano; Yoshihisa Nakatani; Masahiro Hatazaki; Takashi Tamatani; Kazuya Yamagata; Jun-Ichiro Miyagawa; Yasuko Kitao; Osamu Hori; Yoshimitsu Yamasaki; Satoshi Ogawa
Journal:  Diabetes       Date:  2005-03       Impact factor: 9.461

6.  Impairment of hepatic Stat-3 activation and reduction of PPARalpha activity in fructose-fed rats.

Authors:  Núria Roglans; Laia Vilà; Mireia Farré; Marta Alegret; Rosa María Sánchez; Manuel Vázquez-Carrera; Juan Carlos Laguna
Journal:  Hepatology       Date:  2007-03       Impact factor: 17.425

7.  Biological activities of the LXRα and β agonist, 4β-hydroxycholesterol, and of its isomer, 4α-hydroxycholesterol, on oligodendrocytes: effects on cell growth and viability, oxidative and inflammatory status.

Authors:  Thomas Nury; Mohammad Samadi; Alexis Varin; Tatiana Lopez; Amira Zarrouk; Mohamed Boumhras; Jean-Marc Riedinger; David Masson; Anne Vejux; Gérard Lizard
Journal:  Biochimie       Date:  2012-12-07       Impact factor: 4.079

8.  Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents.

Authors:  Tsuguhito Ota; Constance Gayet; Henry N Ginsberg
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

9.  Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.

Authors:  Julie Tsai; Rianna Zhang; Wei Qiu; Qiaozhu Su; Mark Naples; Khosrow Adeli
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-02       Impact factor: 4.052

10.  Apolipoprotein B100 acts as a molecular link between lipid-induced endoplasmic reticulum stress and hepatic insulin resistance.

Authors:  Qiaozhu Su; Julie Tsai; Elaine Xu; Wei Qiu; Erika Bereczki; Miklos Santha; Khosrow Adeli
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

View more
  25 in total

1.  Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats.

Authors:  Xiang Qiu; Dan-Hong Gao; Xiao Xiang; Yu-Fang Xiong; Teng-Shi Zhu; Lie-Gang Liu; Xiu-Fa Sun; Li-Ping Hao
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

Review 2.  Liver function and dysfunction - a unique window into the physiological reach of ER stress and the unfolded protein response.

Authors:  D Thomas Rutkowski
Journal:  FEBS J       Date:  2018-02-07       Impact factor: 5.542

Review 3.  Fructose and hepatic insulin resistance.

Authors:  Samir Softic; Kimber L Stanhope; Jeremie Boucher; Senad Divanovic; Miguel A Lanaspa; Richard J Johnson; C Ronald Kahn
Journal:  Crit Rev Clin Lab Sci       Date:  2020-01-14       Impact factor: 6.250

4.  CREBH mediates metabolic inflammation to hepatic VLDL overproduction and hyperlipoproteinemia.

Authors:  Yongyan Song; Miaoyun Zhao; Xiao Cheng; Jing Shen; Rituraj Khound; Kezhong Zhang; Qiaozhu Su
Journal:  J Mol Med (Berl)       Date:  2017-04-28       Impact factor: 4.599

5.  Xanthophyll β-cryptoxanthin treatment inhibits hepatic steatosis without altering vitamin A status in β-carotene 9',10'-oxygenase knockout mice.

Authors:  Chun Liu; Bruna Paola M Rafacho; Xiang-Dong Wang
Journal:  Hepatobiliary Surg Nutr       Date:  2022-04       Impact factor: 7.293

Review 6.  MicroRNAs and Noncoding RNAs in Hepatic Lipid and Lipoprotein Metabolism: Potential Therapeutic Targets of Metabolic Disorders.

Authors:  Neetu Sud; Jennifer Taher; Qiaozhu Su
Journal:  Drug Dev Res       Date:  2015-08-19       Impact factor: 4.360

7.  Glucocorticoid receptor-PPARα axis in fetal mouse liver prepares neonates for milk lipid catabolism.

Authors:  Gianpaolo Rando; Chek Kun Tan; Nourhène Khaled; Alexandra Montagner; Nicolas Leuenberger; Justine Bertrand-Michel; Eeswari Paramalingam; Hervé Guillou; Walter Wahli
Journal:  Elife       Date:  2016-07-01       Impact factor: 8.140

Review 8.  The role of ER stress in lipid metabolism and lipotoxicity.

Authors:  Jaeseok Han; Randal J Kaufman
Journal:  J Lipid Res       Date:  2016-05-04       Impact factor: 5.922

9.  Activation of dsRNA-Dependent Protein Kinase R by miR-378 Sustains Metabolic Inflammation in Hepatic Insulin Resistance.

Authors:  Hao Wang; Yongyan Song; Yuxin Wu; Virender Kumar; Ram I Mahato; Qiaozhu Su
Journal:  Diabetes       Date:  2021-01-08       Impact factor: 9.461

10.  Small heterodimer partner (SHP) aggravates ER stress in Parkinson's disease-linked LRRK2 mutant astrocyte by regulating XBP1 SUMOylation.

Authors:  Jee Hoon Lee; Ji-Hye Han; Eun-Hye Joe; Ilo Jou
Journal:  J Biomed Sci       Date:  2021-07-07       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.